Menopause Profile Dubai – Comprehensive 54-Biomarker Assessment at Home
Vesta Care's Menopause Profile delivers complete hormonal and health evaluation for women experiencing menopausal transition, confirming menopausal status, and assessing overall health during this critical life stage. This extensive 54-biomarker assessment measures reproductive hormones (FSH, LH, estradiol, progesterone, prolactin), complete thyroid function, metabolic markers (glucose, lipid profile), organ health (kidney function), blood and urine analysis, iron status, and pregnancy exclusion (beta-HCG)—providing the comprehensive picture essential for managing menopausal symptoms and preventing long-term health complications.
At AED 429, this specialized screening distinguishes perimenopause from menopause, identifies hormone imbalances requiring treatment, detects thyroid dysfunction mimicking menopausal symptoms, and establishes baselines for cardiovascular and metabolic health monitoring—enabling evidence-based decisions about hormone replacement therapy and lifestyle interventions supporting healthy aging.
Understanding Menopause Biomarkers
FSH levels above 30 IU/L indicate perimenopause, while postmenopausal women commonly show FSH levels of 70-90 IU/L as declining estrogen fails to suppress pituitary FSH production. This dramatic FSH elevation represents the hallmark laboratory marker of ovarian aging—when follicles no longer respond to stimulation, the brain compensates by producing increasingly higher FSH attempting to trigger ovulation.
Repeatedly high FSH levels over time combined with low estradiol levels and absent menstruation for 12 months confirms postmenopausal status. However, during perimenopause, hormone levels fluctuate wildly—explaining why single FSH measurements prove unreliable for diagnosis. Comprehensive hormone panels tracking FSH, LH, estradiol, and progesterone patterns provide clearer diagnostic information than isolated measurements.
Estradiol levels drop from premenopausal ranges of 25-75 pg/mL to below 25 pg/mL within five years post-menopause in women not receiving hormone replacement therapy. This estrogen decline drives the classic menopausal symptoms—hot flashes, night sweats, vaginal dryness, sleep disturbances, mood changes, cognitive difficulties, and bone loss. Measuring current estradiol levels guides hormone replacement therapy decisions and dosing.
Thyroid function testing proves essential because thyroid disorders frequently emerge during menopausal transition and cause symptoms identical to menopause—fatigue, weight changes, mood disturbances, irregular periods. The lipid profile identifies cardiovascular risk elevation occurring after menopause when estrogen's protective effects disappear. Complete blood count detects anemia causing fatigue misattributed to menopause. Urinalysis screens for urinary tract changes common during menopausal transition. Beta-HCG excludes pregnancy in women with irregular cycles.
Who Needs Menopause Testing?
This comprehensive profile suits women experiencing menopausal transition:
- Irregular or absent periods after age 40 suggesting perimenopause
- Hot flashes and night sweats disrupting sleep and daily activities
- Mood changes or depression potentially hormone-related
- Vaginal dryness or discomfort affecting quality of life
- Premature menopause symptoms before age 45 requiring evaluation
- Considering hormone replacement therapy needing baseline assessment
- Uncertain menopausal status after hysterectomy or irregular cycles
Women with family history of early menopause, those who underwent chemotherapy or radiation affecting ovaries, or anyone experiencing unexplained symptoms potentially related to hormonal changes benefit from comprehensive evaluation confirming menopausal status and identifying treatment needs.
Professional At-Home Collection
Requires 8-10 hours fasting for accurate glucose and lipid measurement—schedule early morning collection after overnight fast, with water permitted. Both blood and urine samples collected during single appointment. Our DHA-licensed phlebotomist arrives at your Dubai location with all equipment for professional specimen collection.
Blood sample drawn through standard venipuncture within minutes. Urine sample collected in sterile container provided by phlebotomist following proper collection technique instructions. The 54-biomarker panel analyzes both specimens comprehensively across multiple laboratory departments.
Samples reach our CAP-accredited laboratory through temperature-controlled logistics maintaining specimen integrity. Advanced analyzers measure each biomarker with precision: chemiluminescent immunoassay for reproductive hormones and thyroid, enzymatic assays for glucose and lipids, automated hematology for CBC, spectrophotometry for kidney function, and microscopic urinalysis for cellular elements and chemistry.
24-Hour Comprehensive Results
Results arrive electronically within 24 hours—providing rapid confirmation of menopausal status and identification of health concerns. Our DHA-licensed Clinical Pathologist reviews every result before release, identifying characteristic perimenopause or menopause hormone patterns, recognizing thyroid dysfunction requiring separate treatment, detecting cardiovascular risk factors, noting anemia or urinary abnormalities, and flagging concerning results requiring immediate attention.
Complimentary medical consultation follows result delivery. Our DHA-licensed doctors explain hormone patterns confirming menopausal stage, discuss symptom management options including hormone replacement therapy benefits and risks, recommend cardiovascular and bone health monitoring appropriate for menopausal status, arrange gynecology or endocrinology referrals for complex cases, and provide evidence-based guidance on lifestyle modifications supporting healthy aging during menopausal transition.
Comprehensive Menopause Management
At AED 429, the Menopause Profile provides essential comprehensive assessment for women navigating menopausal transition—superior to isolated FSH testing missing the complete health picture. Menopause represents not just reproductive cessation but a critical health transition affecting cardiovascular risk, bone density, metabolic function, and overall wellbeing requiring comprehensive evaluation.
This 54-biomarker analysis establishes baselines for long-term health monitoring, identifies which symptoms truly relate to hormonal changes versus other treatable conditions, guides hormone replacement therapy decisions through accurate current hormone measurement, and detects emerging health risks requiring preventive intervention during this vulnerable transition period.
Book Your Menopause Assessment Today
Schedule your Menopause Profile through Vesta Care at +971 52 270 4729. Our service operates throughout Dubai with same-day appointments, professional fasted blood and urine collection, 24-hour comprehensive results, specialist pathologist review, and complimentary medical consultation. Payment accepts cash and credit cards.
Take control of your menopausal health journey. Comprehensive 54-biomarker testing confirms menopausal status, guides symptom management decisions, and establishes health baselines supporting informed choices about hormone therapy and preventive care—book your complete menopause evaluation now.



.png)
.png)




